ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,262Medicare Part D Prescriptions Filled, Including Refills

Rank: 81 out of 2094

$1.22M Total Retail Price of All Prescriptions

Rank: 48 out of 2094

610 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 610 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 10,089 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SPIRIVA 423 367 1 60
FUROSEMIDE 414 365 2 6
AMLODIPINE BESYLATE 391 343 3 2
OMEPRAZOLE 342 259 4 4
METFORMIN HCL 322 214 5 8
LEVOTHYROXINE SODIUM 317 253 6 3
ADVAIR DISKUS 313 256 7 36
ATORVASTATIN CALCIUM 260 213 8 5
SIMVASTATIN 252 163 9 1
AZITHROMYCIN 241 178 10 27
PREDNISONE 221 182 11 54
METOPROLOL TARTRATE 208 179 12 10
POTASSIUM CHLORIDE 193 172 13 24
LISINOPRIL 192 123 14 7
METOPROLOL SUCCINATE 184 140 15 9
FLUTICASONE PROPIONATE 176 136 16 41
HYDROCODONE-ACETAMINOPHEN 176 129 S3 16 42
TRAMADOL HCL 159 99 18 33
PROAIR HFA 153 101 19 45
DIOVAN 141 138 20 13
HYDROCHLOROTHIAZIDE 138 97 21 12
WARFARIN SODIUM 134 117 22 11
LEVOFLOXACIN 131 110 23 70
SPIRONOLACTONE 121 90 24 93
DILTIAZEM 24HR CD 114 99 25 110
PANTOPRAZOLE SODIUM 111 99 26 37
CEFUROXIME 108 81 27 137
ZOLPIDEM TARTRATE 107 90 28 14
COMBIVENT 105 61 29 211
CARVEDILOL 104 73 30 19
ESCITALOPRAM OXALATE 103 82 31 46
KLOR-CON M20 102 74 32 106
FLOVENT HFA 95 93 33 242
MELOXICAM 94 58 34 49
CLOPIDOGREL 93 86 35 22
NEXIUM 93 66 35 16
PLAVIX 86 81 37 38
LOSARTAN-HYDROCHLOROTHIAZIDE 84 72 38 52
ALENDRONATE SODIUM 84 73 38 30
GABAPENTIN 82 43 40 23
CRESTOR 81 68 41 15
SERTRALINE HCL 81 75 41 26
DIGOXIN 81 69 41 51
PRAMIPEXOLE DIHYDROCHLORIDE 79 34 44 250
SYMBICORT 79 54 44 149
NITROGLYCERIN PATCH 79 79 44 101
LOVASTATIN 77 53 47 121
LIPITOR 77 55 47 39
TRICOR 77 16 47 99
AMLODIPINE BESYLATE-BENAZEPRIL 74 53 50 58
CYMBALTA 73 59 51 61
PRAVASTATIN SODIUM 70 68 52 18
SINGULAIR 69 43 53 64
JANUVIA 68 59 54 35
DIOVAN HCT 68 64 54 28
DONEPEZIL HCL 67 67 56 20
ACTOS 65 43 57 112
LEVOXYL 64 41 58 130
ATENOLOL 63 60 59 21
GLIMEPIRIDE 63 48 59 31
ZETIA 62 42 61 79
ENALAPRIL MALEATE 62 59 61 25
LOSARTAN POTASSIUM 61 61 63 17
CIPROFLOXACIN HCL 61 53 63 81
ALLOPURINOL 58 52 65 50
AMITRIPTYLINE HCL 56 23 R 66 178
NYSTATIN-TRIAMCINOLONE 55 46 67 207
RANITIDINE HCL 55 55 67 80
BENAZEPRIL HCL 52 29 69 154
LEVEMIR FLEXPEN 51 29 70 188
VENLAFAXINE HCL ER 51 20 70 183
CITALOPRAM HBR 50 48 72 47
LYRICA 50 27 72 85
GLIPIZIDE 50 34 72 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.